Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- Check5 days agoChange DetectedA new revision tag v3.6.4 was added to the page, indicating a newer build. The previous revision tag v3.6.3 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows a new revision entry, Revision: v3.6.3, replacing Revision: v3.6.2, indicating a software version update for the page. This change does not alter study data, eligibility criteria, or results.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now shows revision v3.6.2 instead of v3.6.0, indicating a small site update to the revision tag. The study details and layout remain unchanged.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page adds sections for No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and a revised Intervention/Treatment area. A Revision: v3.6.0 note accompanies the update.SummaryDifference0.4%

- Check55 days agoChange DetectedFooter shows Revision: v3.5.5, replacing v3.5.4, indicating a new site release. It does not alter study details or how users access the trial information.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4. This indicates a newer version of the page documentation rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.